Cytokine and Chemokine Control of Cellular Immunity

 Tuesday, May 10, 2022     8:00 AM – 10:00 AM ET     Room C123–124

Cytokine and Chemokine Control of Cellular Immunity

Chairs

• Thomas Malek, Miller Sch. of Med., Univ. of Miami
• Robert Welner, Univ. of Alabama at Birmingham

Speakers

• Sergio Pontejo, NIAID, NIH, Chemokines and anionic phospholipids: new binding partners for microbial killing and apoptotic cell clearance
• Haressh Sajiir, Mater Res. Inst., Univ. of Queensland, Pancreatic interleukin-22 receptor signaling is critical in maintaining beta-cell insulin production and is hepatoprotective
• Victoria Matkins, Univ. of Alabama at Birmingham, Perturbations of Marrow Stromal Cell function during Acute Inflammation
• Elizabeth M. Hill, Univ. of Maryland Sch. of Med., Collaboration of therapeutic, systemic IL12p40 with locally released IL12p35 focuses immunity to the tumor microenvironment
• Marine Rousseau, Université de Montréal, Characterization of a new cytokine complex from the IL-6/IL-12 family
• Rebecca Martin, Virginia Commonwealth Univ. Sch. of Med., Loss of ADAM17 from macrophages induces ST2⁺ T regulatory cells that limit obesity-induced metabolic inflammation in mice through changes in both membrane and soluble TNF
• Acaci Crouch, Univ. of Miami Leonard M. Miller Sch. of Med., Interleukin-2 signaling engages de novo cholesterol biosynthesis in regulatory T cells